Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 2091-2112
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2091
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2091
Figure 2 Correlation and prognostic value analysis of plexin domain-containing 1 gene methylation sites in hepatocellular carcinoma.
A: Methylation sites associated with plexin domain-containing 1 expression. r: Correlation; probe ID: Methylation site; aP < 0.05; bP < 0.01; cP < 0.001; B: Sites for which the methylation level was positively correlated with survival: The survival rate of the high-methylation group was significantly lower than that of the control group; C: Sites for which the methylation level was negatively correlated with survival: The survival rate of the high methylation group was significantly lower than that of the control group. PLXDC1: Plexin domain-containing 1.
- Citation: Tang MY, Shen X, Yuan RS, Li HY, Li XW, Jing YM, Zhang Y, Shen HH, Wang ZS, Zhou L, Yang YC, Wen HX, Su F. Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion. World J Gastrointest Oncol 2024; 16(5): 2091-2112
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/2091.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.2091